Charles Schwab stock gains on analyst support

Published on 09/20/2026 at 14:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Charles Schwab stock drew a Buy call from Barclays at USD 125 on September 16, 2026. The latest cited quarter showed revenue of USD 5.4 billion and EPS of USD 1.00.

Fotorealistischer Handelsraum mit Börsencharts und Stadtblick, Finanzdienstleistungen — Charles Schwab Corp. US8085131050 fotorealistischer moderner Handelsraum mit Monitoren und Stadtpanorama im Hintergrund, Illustration mit AI erstellt.

Charles Schwab stock (US8085131055) is drawing attention after Barclays' Benjamin Budish kept a Buy rating and a USD 125 target on September 16, 2026, according to a recent market summary. The same coverage ties the call to current peer valuation work on listed wealth managers.

Analyst support stays firm

That Barclays view matters because it gives the shares a clear reference point: a USD 125 target against a live market price backdrop, with the target maintained on September 16, 2026. In the same cited peer table, Charles Schwab sits alongside other listed financial names in a sector where rates, deposits and asset flows still set the tone.

For investors, the number that stands out is the spread between the target and the share price. The call signals continued confidence in Charles Schwab's earnings power rather than a fresh thesis change.

Latest quarter still anchors valuation

The most recent reported quarter named in the available market coverage remains the second quarter of 2026, when Charles Schwab posted revenue of USD 5.4 billion and earnings per share of USD 1.00. Those figures give the stock a current operating base to judge against the analyst view.

That quarter also matters because the same source set frames the result as the latest visible reporting period, which keeps the focus on revenue and EPS rather than on a stale historical comparison. The market is still reading Schwab through its most recent reported numbers.

Price and range

Charles Schwab stock traded at USD 92.14 on September 18, 2026, with a 52-week range of USD 61.01 to USD 99.68. The shares therefore sat closer to the upper end of that band than to the low.